Table 1 Clinical measures by mutation... | American Society of Hematology

Table 1

Clinical measures by mutation status for both cohorts

	MDS	CCUS	Nonclonal ICUS	P
Group size, N	115	136	233
Male:female ratio	1.0	1.65	0.68	.0003
Age, mean (SD), y	74.3 (10.4)	75.1 (12.5)	66.6 (13.6)	<.0001*
Hgb, mean (SD), g/dL	9.8 (1.8)	10.7 (1.8)	11.1 (2.0)	<.0001†
ANC, mean (SD), ×10⁹/L	3.2 (2.1)	3.5 (2.3)	3.4 (2.4)	.71
Platelets, mean (SD), ×10⁹/L	184 (110)	164 (104)	179 (101)	.27

	MDS	CCUS	Nonclonal ICUS	P
Group size, N	115	136	233
Male:female ratio	1.0	1.65	0.68	.0003
Age, mean (SD), y	74.3 (10.4)	75.1 (12.5)	66.6 (13.6)	<.0001*
Hgb, mean (SD), g/dL	9.8 (1.8)	10.7 (1.8)	11.1 (2.0)	<.0001†
ANC, mean (SD), ×10⁹/L	3.2 (2.1)	3.5 (2.3)	3.4 (2.4)	.71
Platelets, mean (SD), ×10⁹/L	184 (110)	164 (104)	179 (101)	.27

ANC, absolute neutrophil count; SD, standard deviation.

No difference between MDS and CCUS (P = .87).

No difference between CCUS and ICUS (P = .21).